AMISULPRIDE VERSUS BROMOCRIPTINE IN INFANTILE AUTISM: A CONTROLLED CROSSOVER COMPARATIVE STUDY OF TWO DRUGS WITH OPPOSITE EFFECTS ON DOPAMINERGIC FUNCTION
Saved in:
DOLLFUS, S., ET AL., AMISULPRIDE VERSUS BROMOCRIPTINE IN INFANTILE AUTISM: A CONTROLLED CROSSOVER COMPARATIVE STUDY OF TWO DRUGS WITH OPPOSITE EFFECTS ON DOPAMINERGIC FUNCTION. JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, Vol. 22, no. 1 (1992), p. 47-60.
Ref.
30011
Location:
SIIS R.237 Depósito (19)
Palabras clave:
Autismo, Discapacidad, Discapacidad del lenguaje, Discapacidad intelectual, Fármacos, Trastornos del espectro autista, Tratamiento
Autismo, Discapacidad, Discapacidad del lenguaje, Discapacidad intelectual, Fármacos, Trastornos del espectro autista, Tratamiento
Similar Items: AMISULPRIDE VERSUS BROMOCRIPTINE IN INFANTILE AUTISM: A CONTROLLED CROSSOVER COMPARATIVE STUDY OF TWO DRUGS WITH OPPOSITE EFFECTS ON DOPAMINERGIC FUNCTION
- A CONTROLLED CROSSOVER TRIAL OF FENFLURAMINE IN AUTISM
- BLINK RATE ABNORMALITIES IN AUTISTIC AND MENTALLY RETARDED CHILDREN: RELATIONSHIP TO DOPAMINERGIC ACTIVITY
- MAXIMAL OPPOSITION APPROACH TO PHONOLOGICAL TREATMENT
- ETUDE PHARMACOCLINIQUE D'UN AGONISTE ET D'UN ANTAGONISTE DE LA DOPAMINE DANS L'AUTISME INFANTILE PRECOCE
- PSYCHOLOGICAL AND NEUROBEHAVIORAL COMPARISONS OF CHILDREN WITH ASPERGER'S DISORDER VERSUS HIGH-FUNCTIONING AUTISM
- Symptoms of autism and schizophrenia spectrum disorders in clinically referred youth with oppositional defiant disorder